glp-1/gip receptor agonist Dual | Tirzepatide | Obesity & T2DM Mx | Harrison's Update(22nd Ed.) The Road towards Triple Agonists:

With the right approach, the benefits of GLP-1 medications often far outweigh the risks

This becomes particularly important since inflammation in people with obesity may reduce blood-brain barrier integrity 28

DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption

Archived from the original on September 1, 2015

Victoza (liraglutide) : a once-daily injectable GLP-1 receptor agonist, also sold in a higher dose for weight loss under the brand name Saxenda

Data analysed by paired two-tailed Students t-test ( j - m ), unpaired two-tailed Students t-test ( p and r ), one-way ANOVA, multiple comparison, Bonferroni post hoc test ( h ) and two-way repeated measures ANOVA to assess main effects of treatment ( c , d and s - v )